share_log

復宏漢霖:自願公告 - HLX6018用於特發性肺纖維化治療的臨床試驗申請獲國家藥品監督管理局批准

HENLIUS: VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL OF HLX6018 WAS APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

香港交易所 ·  Mar 12 06:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more